Progress and problems in nutraceuticals delivery

Journal of Bioequivalence and Bioavailability

Volumn 6, Issue 3, 2014, Pages 075-077

  Zaki, Noha M ^a  

^a TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Bioavailability; Delivery oral; Nanotechnology; Nutraceuticals; Probiotics; Solubility enhancement; Targeting

Indexed keywords

ANTHOCYANIN; CAROTENOID; CURCUMIN; ELLAGIC ACID; FLAVANONE; ISOFLAVONE; NANOCAPSULE; NANOPARTICLE; NUTRACEUTICAL; OMEGA 3 FATTY ACID; PROANTHOCYANIDIN; PROBIOTIC AGENT; RESVERATROL; THYMOQUINONE; TRIACYLGLYCEROL; UBIDECARENONE; VITAMIN;

ARTICLE; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; INTESTINE MUCOSA PERMEABILITY; MITOCHONDRIAL TARGETING SIGNAL;

EID: 84904022460     PISSN: None     EISSN: 09750851     Source Type: Journal    
DOI: 10.4172/jbb.1000183     Document Type: Article

References (43)

1. http://wwwfoodinsightorg/Resources/Detailaspx?topic=2005.
2. Gonzalez-Sarrias A, Larrosa M, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC (2013) Nutraceuticals for older people: facts, fictions and gaps in knowledge. Maturitas 75: 313-334.
3. Espin JC, Garcia-Conesa MT, Tomas-Barberan FA (2007) Nutraceuticals: facts and fiction. Phytochemistry 68: 2986-3008.
4. Tang H, Murphy CJ, Zhang B, Shen Y, Van Kirk EA, et al. (2010) Curcumin polymers as anticancer conjugates. Biomaterials 31: 7139-7149.
5. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37: 223-230.
6. Prajakta D, Ratnesh J, Chandan K, Suresh S, Grace S, et al. (2009) Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol 5: 445-455.
7. Narayanan NK, Nargi D, Randolph C, Narayanan BA (2009) Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125: 1-8.
8. Kendler BS (1999) Nutritional strategies in cardiovascular disease control: an update on vitamins and conditionally essential nutrients. Prog Cardiovasc Nurs 14: 124-129.
9. Borek C (2006) Aging and antioxidants. Fruits and vegetables are powerful armor. Adv Nurse Pract 14: 35-38.
10. Woo CC, Kumar AP, Sethi G, Tan KH (2012) Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol 83: 443-451.
11. Singh A, Ahmad I, Akhter S, Jain GK, Iqbal Z, et al. (2013) Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies. Colloids Surf B Biointerfaces 102: 822-832.
12. Shah M, Naseer MI, Choi MH, Kim MO, Yoon SC (2010) Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. Int J Pharm 400: 165-175.
13. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.
14. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, et al. (2009) Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 374: 66-72.
15. Palamakula A (2004) Biopharmaceutical classification and development of limonene-based self-nanoemulsified capsule dosage form of coenzyme q10. Texas Tech University Sciences Center 5: 55-79.
16. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV (2012) Microencapsulation of probiotics for gastrointestinal delivery. J Control Release 162: 56-67.
17. Hafez MM, Maghrabi IA, Zaki NM (2013) Toward an alternative therapeutic approach for skin infections: Antagonistic activity of lactobacilli against antibiotic-resistant staphylococcus aureus and pseudomonas aeruginosa. Probiotics and Antimicrobial Proteins.
18. Gbassi GK, Vandamme T (2012) Probiotic encapsulation technology: from microencapsulation to release into the gut. Pharmaceutics 4: 149-163.
19. Chen S, Zhao Q, Ferguson LR, Shu Q, Weir I, et al. (2011) Development of a novel probiotic delivery system based on microencapsulation with protectants. Appl Microbiol Biotechnol.
20. Champagne CP (2012) Microencapsulation of probiotics in food: challenges and future prospects. Ther Deliv 3: 1249-1251.
21. New RRC, Kirby CJ (1999) Solubilisation aids. US Patent 5968549.
22. Yallapu MM, Jaggi M, Chauhan SC (2010) beta-Cyclodextrin-curcumin selfassembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 79: 113-125.
23. 2-cyclodextrin)/curcumin selfassembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol Biosci 10: 1141-1151.
24. Abu-Dahab R, Odeh F, Ismail SI, Azzam H, Al Bawab A (2013) Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles. Pharmazie 68: 939-944.
25. Yallapu MM, Jaggi M, Chauhan SC (2013) Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des 19: 1994-2010.
26. Yallapu MM, Jaggi M, Chauhan SC (2012) Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 17: 71-80.
27. Yallapu MM, Jaggi M, Chauhan SC (2010) Scope of nanotechnology in ovarian cancer therapeutics. J Ovarian Res 3: 19.
28. Song XR, Cai Z, Zheng Y, He G, Cui FY, et al. (2009) Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci 37: 300-305.
29. Ravindran J, Nair HB, Sung B, Prasad S, Tekmal RR, et al. (2010) Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced antiproliferative, anti-inflammatory, and chemosensitization potential. Biochem Pharmacol 79: 1640-1647.
30. Patil Y, Panyam J (2009) Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm 367: 195-203.
31. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(D, Llactide-co-glycolide) and its derivatives. J Control Release 125: 193-209.
32. Chavanpatil MD, Patil Y, Panyam J (2006) Susceptibility of nanoparticleencapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int J Pharm 320: 150-156.
33. Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, et al. (2009) PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 30: 1627-1634.
34. Cegnar M, Kos J, Kristl J (2006) Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles. J Nanosci Nanotechnol 6: 3087-3094.
35. Acharya S, Dilnawaz F, Sahoo SK (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30: 5737-5750.
36. Zaki NM, Tirelli N (2011) Assessment of nanomaterials cytotoxicity and internalization. Methods Mol Biol 695: 243-259.
37. Zaki NM, Tirelli N (2010) Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin Drug Deliv 7: 895-913.
38. Zaki NM, Nasti A, Tirelli N (2011) Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model. Macromol Biosci 11: 1747-1760.
39. Zaki NM (2013) Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients. Drug Deliv.
40. CochemA HM, Kelso GF, James AM, Ross MF, Trnka J, et al. (2007) Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 7 Suppl: S94-102.
41. Biasutto L, Mattarei A, Marotta E, Bradaschia A, Sassi N, et al. (2008) Development of mitochondria-targeted derivatives of resveratrol. Bioorg Med Chem Lett 18: 5594-5597.
42. Porteous CM, Logan A, Evans C, Ledgerwood EC, Menon DK, et al. (2010) Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. Biochim Biophys Acta 1800: 1009-1017.
43. Safavy A, Raisch KP, Mantena S, Sanford LL, Sham SW, et al. (2007) Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem 50: 6284-6288.